InvestSMART

Integrated Research Limited (ASX: IRI) - ETF Exposure

- Current share price for IRI : $0.295

Integrated Research Limited (IRI) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is the global provider of user experience and performance management solutions for payment transactions and collaborative systems. Its principal activities are the design, development, implementation, and sale of software to monitor in real time the performance of business-critical computing, including Unified Communication networks and Payment networks.

IRI General Information +

ASX Code IRI
Website N/A
Industry/Sector Application Software
Market Cap ($M) 53
IRI Share Price $0.295
Day High $0.295
Day Low $0.295
Last Close $0.295
IRI Share Price Movement - ( No change )
Prices as at 16:40, 21 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to IRI

Integrated Research Limited (IRI) is held across 1 ETF spanning strategies that include application software exposure . Its weighting in those funds means performance can have an outsized influence - when IRI moves, funds like DACE that hold it can move with it.

For more concentrated exposure, ETFs such as DACE (Dimensional Australian Core Equity (Managed Fund)) allocate about 0% to IRI , while the average exposure across all 1 ETF that hold it is around 0% .

Top ETF holdings

Last updated: ETF data and holdings as at 23 August 2026

Own IRI directly or through an ETF?

How does holding Integrated Research Limited (IRI) shares directly compare to ETFs that include it?

IRI Direct
DACE
ASX
Holdings 1 company 470 holdings
IRI Weight 100% 0%
Diversification Single Stock Broad
Annual Cost Brokerage only 0.28% p.a.
Approx. Yield - 2.95%
Star Ratings - starstarstarstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not IRI's direct yield. Annual cost uses each ETF's MER.

IRI Exposure on $10,000 investment

How a $10,000 investment in Integrated Research Limited (IRI) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Integrated Research Limited (IRI) Direct share $0.295 0% $0 $10,000
Dimensional Australian Core Equity (Managed Fund) (DACE) Equity - Australia Strategy $19.340 0.42% +$42 $10,042

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Integrated Research Limited (IRI) ETFs

1 ETF hold Integrated Research Limited (IRI).

ETF IRI Weight MER Yield
Dimensional Australian Core Equity (Managed Fund) (DACE) 0% 0.28% 2.95%

Integrated Research Limited (IRI) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 100% 3 Sep 2025 21 Oct 2025 - - -
HFResult 100% 2 Sep 2024 15 Oct 2024 - - -
HFResult 3.75¢ 100% 2 Sep 2020 15 Oct 2020 - - -

See all dividends from Integrated Research Limited (IRI) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Integrated Research Limited (IRI) price-sensitive announcements

IRI - FY26 Results Trading Update
Integrated Research Limited's FY26 revenue performance faced challenges due to a softer re
Integrated Research Limited (IRI)
24 Jul 2026 | 10:01 AM
IRI - FY26 Interim Results
Integrated Research Limited reported its FY26 interim results, showing a slight revenue de
Integrated Research Limited (IRI)
26 Feb 2026 | 8:43 AM
IRI - Appendix 4D & Interim Financial Report
Integrated Research Limited's interim financial report for the half-year ended 31 December
Integrated Research Limited (IRI)
26 Feb 2026 | 8:42 AM
IRI - Annual General Meeting - CEO's Presentation
The CEO's presentation at the 2025 Annual General Meeting of Integrated Research Limited h
Integrated Research Limited (IRI)
24 Nov 2025 | 9:20 AM

Integrated Research Limited (IRI) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Integrated Research Limited (IRI)
ORDINARY FULLY PAID
Information Technology $53 FY26 Earnings Release & Webinar Details 17 Aug 2026 8:10AM $0.295 $0.295 fallen by 0%
Integrated Research Limited (IRI)
ORDINARY FULLY PAID
Information Technology $53 FY26 Results Trading Update 24 Jul 2026 10:01AM $0.290 $0.295 risen by 1.72%
Integrated Research Limited (IRI)
ORDINARY FULLY PAID
Information Technology $53 Notification of cessation of securities - IRI 14 Jul 2026 8:26AM $0.275 $0.295 risen by 7.27%
Integrated Research Limited (IRI)
ORDINARY FULLY PAID
Information Technology $53 Change in substantial holding 24 Jun 2026 8:29AM $0.280 $0.295 risen by 5.36%
Integrated Research Limited (IRI)
ORDINARY FULLY PAID
Information Technology $53 Notification of cessation of securities - IRI 14 Apr 2026 11:35AM $0.310 $0.295 fallen by 4.84%
Integrated Research Limited (IRI)
ORDINARY FULLY PAID
Information Technology $53 Investor Session Presentation 24 Mar 2026 3:03PM $0.300 $0.295 fallen by 1.67%

IRI Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A $12.14 $6.80 -55.50% 8.10 2.00 3.70% 100.0%
2024A $27.13 $15.20 925.70% 2.70 0.00 0.00% 100.0%
2023A $2.55 $1.50 66.30% 29.90 0.00 0.00% 0.0%

IRI Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Life360 Inc (360) $3,716M -32.1265 -0.4506 1.1281 20.9420 38.1159 17.9104 0.00% 0.00% 0.00%
Integrated Research Limited (IRI) $53M -0.5553 0.0000 0.0000 4.3704 0.0000 0.0000 6.78% 0.00% 0.00%
Technology One Limited (TNE) $10,626M 0.1582 0.1924 0.2094 77.7858 65.2331 53.9382 1.13% 1.06% 1.28%
Wisetech Global Limited (WTC) $14,525M 0.3104 -0.1210 0.5433 40.6303 46.2222 29.9494 0.51% 0.47% 0.63%
Xero Limited (XRO) $14,555M 0.0000 0.0000 0.5724 0.0000 73.1099 46.4948 0.00% 0.00% 0.00%

IRI Directors

Name Position Start Date
Mr Ian Lowe Chief Executive Officer, Managing Director 17 Oct 2024
Mr Mark Ronald Brayan Non-Executive Director 22 Nov 2023
Ms Kate Greenhill Non-Executive Director 19 Apr 2024
Mr Michael Hitz Non-Executive Director 23 Oct 2023
Mr Peter Lloyd Non-Executive Director, Non-Executive Chairman 15 Jul 2010

Integrated Research Limited (IRI) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
5 Dec 2025 HITZ, Michael Buy Indirect Shares 149,500 $0.347 $51,948.570
1 Dec 2025 HITZ, Michael Buy Indirect Shares 150,500 $0.314 $47,250.980
27 Nov 2025 GREENHILL, Kate Buy Direct Shares 90,000 $0.312 $28,088.400

See all changes in directors' interest & trades for Integrated Research Limited (IRI) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

IRI Management

Name Position
Christian Shaw Chief Financial Officer
Leanne Ralph Company Secretary

IRI Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Integrated Research Limited (IRI). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
52,218,231 (28.92%) Stephen John Killelea

IRI Calendar of Events

Date Event
25 February 2027 Report (Interim)
16 October 2026 Report (Annual)
25 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.